SCOPUS 정보 검색 플랫폼

Volumn 83, Issue 2, 2001, Pages 394-399

A dose-escalating study of weekly bolus topotecan in previously treated ovarian cancer patients

(8) Homesley, Howard D a Hall, Don J b Martin, David A b Lewandowski, George S c Vaccarello, Luis c Nahhas, William A d Suggs, Charles L e Penley, Rebecca G a

a Brookview Research Inc (United States)

b Baptist Hospital West (United States)

c Gynecologic Oncology and Pelvic Surgery (United States)

d WRIGHT STATE UNIVERSITY (United States)

e Harvard Center (United States)

Author keywords

Cancer antigen 125; Dose escalation; Dose limiting tolerability; Myelotoxicity; Ovarian cancer; Topoisomerase I; Topotecan

Indexed keywords

CA 125 ANTIGEN; DNA TOPOISOMERASE INHIBITOR; RECOMBINANT ERYTHROPOIETIN; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; TOPOTECAN;

ADULT; AGED; ALOPECIA; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CHRONIC FATIGUE SYNDROME; CLINICAL ARTICLE; CONTROLLED STUDY; DOSE CALCULATION; DRUG SAFETY; DRUG TOLERABILITY; DYSPNEA; FEMALE; GASTROINTESTINAL TOXICITY; HUMAN; LEUKOPENIA; MAXIMUM TOLERATED DOSE; NAUSEA; NEUROTOXICITY; NEUTROPENIA; OVARY CANCER; PAIN; PRIORITY JOURNAL; THROMBOCYTOPENIA; VOMITING;

EID: 0034759598 PISSN: 00908258 EISSN: None Source Type: Journal
DOI: 10.1006/gyno.2001.6435 Document Type: Article

Times cited : (74)

References (23)

1
- 0033850178
- Exploratory phase III study of paclitaxel and cisplatin versus paclitaxel and carboplatin in advanced ovarian cancer
- (2000) J Clin Oncol , vol.18 , pp. 3084-3092
- Neijt, J.P.¹ Engelholm, S.A.² Tuxen, M.K.³ Sorensen, P.G.⁴ Hansen, M.⁵ Sessa, C.⁶ De Swart, C.A.⁷ Hirsch, F.R.⁸ Lund, B.⁹ Van Houwelingen, H.C.¹⁰

2
- 0034306857
- Paclitaxel, cisplatin, and epirubicin first-line chemotherapy in stage III and IV ovarian carcinoma: Long-term results of a phase II study
- (2000) Cancer , vol.89 , pp. 1547-1554
- Papadimitriou, C.A.¹ Moulopoulos, L.A.² Vlahos, G.³ Voulgaris, Z.⁴ Kiosses, E.⁵ Georgoulias, N.⁶ Gika, D.⁷ Diakomanolis, E.⁸ Michalas, S.⁹ Dimopoulos, M.A.¹⁰

3
- 0000121237
- Randomized phase III study of cisplatin (CIS)/paclitaxel (PAC) versus carboplatin (CARBO)/PAC in optimal stage III epithelial ovarian cancer (OC): A Gynecologic Oncology Group trial (GOG 158)
- abstract
- (1999) Proc Am Soc Clin Oncol , vol.18
- Ozols, R.F.¹ Bundy, B.N.² Fowler, J.³ Clarke-Pearson, D.⁴ Mannel, R.⁵ Hartenbach, E.M.⁶ Baergen, R.⁷

5
- 0030054309
- Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer
- (1996) N Engl J Med , vol.334 , pp. 1-6
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.L.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

6
- 0031059224
- Comparison of combination therapy with paclitaxel and cisplatin versus cyclophosphamide and cisplatin in patients with suboptimal stage III and stage IV ovarian cancer: A Gynecologic Oncology Group study
- (1997) Semin Oncol , vol.24 , Issue.SUPPL. 2
- McGuire, W.P.¹ Hoskins, W.J.² Brady, M.F.³ Kucera, P.R.⁴ Partridge, E.E.⁵ Look, K.Y.⁶ Clarke-Pearson, D.L.⁷ Davidson, M.⁸

7
- 0022591561
- A randomized trial of cyclophosphamide and doxorubicin with or without cisplatin in advanced ovarian carcinoma
- A Gynecologic Oncology Group Study
- (1986) Cancer , vol.57 , pp. 1725-1730
- Omura, G.¹ Blessing, J.A.² Ehrlich, C.E.³ Miller, A.⁴ Yordan, E.⁵ Creasman, W.T.⁶ Homesley, H.D.⁷

8
- 0031064224
- Efficacy and safety of topotecan in the treatment of advanced ovarian carcinoma
- (1997) Semin Oncol , vol.24 , Issue.SUPPL. 5
- Ten Bokkel Huinink, W.¹ Carmichael, J.² Armstrong, D.³ Gordon, A.⁴ Malfetano, J.⁵

9
- 0031786482
- Topotecan for the treatment of advanced epithelial ovarian cancer: An open-label phase II study in patients treated after prior chemotherapy that contained cisplatin or carboplatin and paclitaxel
- (1998) J Clin Oncol , vol.16 , pp. 3345-3352
- Bookman, M.A.¹ Malmstrom, H.² Bolis, G.³ Gordon, A.⁴ Lissoni, A.⁵ Krebs, J.B.⁶ Fields, S.Z.⁷

10
- 9244247616
- Phase II study of intravenous topotecan as a 5-day infusion for refractory epithelial ovarian carcinoma
- (1996) J Clin Oncol , vol.14 , pp. 1552-1557
- Kudelka, A.P.¹ Tresukosol, D.² Edwards, C.L.³ Freedman, R.S.⁴ Levenback, C.⁵ Chantarawiroj, P.⁶ Gonzalez de Leon, C.⁷ Kim, E.E.⁸ Madden, T.⁹ Wallin, B.¹⁰ Hord, M.¹¹ Verschraegen, C.¹² Raber, M.¹³ Kavanagh, J.J.¹⁴

11
- 0031239998
- Topotecan in platinum- and paclitaxel-resistant ovarian cancer
- (1997) Gynecol Oncol , vol.66 , pp. 480-486
- Swisher, E.M.¹ Mutch, D.G.² Rader, J.S.³ Elbendary, A.⁴ Herzog, T.J.⁵

12
- 10544229791
- Topotecan, an active drug in the second-line treatment of epithelial ovarian cancer: Results of a large European phase II study
- (1996) J Clin Oncol , vol.14 , pp. 3056-3061
- Creemers, G.J.¹ Bolis, G.² Gore, M.³ Scarfone, G.⁴ Lacave, A.J.⁵ Guastalla, J.P.⁶ Despax, R.⁷ Favalli, G.⁸ Kreinberg, R.⁹ Van Belle, S.¹⁰ Hudson, I.¹¹ Verweij, J.¹² Ten Bokkel Huinink, W.W.¹³

13
- 0026537874
- Phase I and pharmacologic study of topotecan: A novel topoisomerase I inhibitor
- (1992) J Clin Oncol , vol.10 , pp. 647-656
- Rowinsky, E.K.¹ Grochow, L.B.² Hendricks, C.B.³ Ettinger, D.S.⁴ Forastiere, A.A.⁵ Hurowitz, L.A.⁶ McGuire, W.P.⁷ Sartorius, S.E.⁸ Lubejko, B.G.⁹ Kaufmann, S.H.¹⁰

14
- 0026697849
- A phase I clinical and pharmacokinetic study of the topoisomerase I inhibitor topotecan (SK&F 104864) given as an intravenous bolus every 21 days
- (1992) Anticancer Drugs , vol.3 , pp. 337-345
- Wall, J.G.¹ Burris III, H.A.² Von Hoff, D.D.³ Rodriguez, G.⁴ Kneuper-Hall, R.⁵ Shaffer, D.⁶ O'Rourke, T.⁷ Brown, T.⁸ Weiss, G.⁹ Clark, G.¹⁰ McVea, S.¹¹ Brown, J.¹² Johnson, R.¹³ Friedman, C.¹⁴ Smith, B.¹⁵ Mann, W.S.¹⁶ Kuhn, J.¹⁷

15
- 0029030737
- Phase I clinical and pharmacokinetic study of topotecan administered by a 24-hour continuous infusion
- (1995) J Clin Oncol , vol.13 , pp. 1768-1776
- Van Warmerdam, L.J.¹ Ten Bokkel Huinink, W.W.² Rodenhuis, S.³ Koier, I.⁴ Davies, B.E.⁵ Rosing, H.⁶ Maes, R.A.⁷ Beijnen, J.H.⁸

16
- 0030749549
- Accelerated titration designs for phase I clinical trials in oncology
- (1997) J Natl Cancer Inst , vol.89 , pp. 1138-1147
- Simon, R.¹ Freidlin, B.² Rubinstein, L.³ Arbuck, S.G.⁴ Collins, J.⁵ Christian, M.C.⁶

17
- 0033856010
- Efficacy and toxicity profile of oral topotecan in a panel of human tumour xenografts
- (2000) Eur J Cancer , vol.36 , pp. 1558-1564
- De Cesare, M.¹ Zunino, F.² Pace, S.³ Pisano, C.⁴ Pratesi, G.⁵

18
- 0002091930
- Activity of topotecan (TPT) 21-day infusion in platinum-treated ovarian cancer and pharmacodynamics of topo-1 depletion
- abstract
- (1996) Ann Oncol , vol.7 , Issue.SUPPL. 5 , pp. 69
- Hochster, H.¹ Speyer, J.² Wadler, S.³ Runowicz, C.⁴ Wallach, R.⁵ Oratz, R.⁶ Chachoua, A.⁷ Sorich, J.⁸ Taubes, B.⁹ Ludwig, G.¹⁰ Broom, C.¹¹

19
- 0001102051
- A phase II study of topotecan given as a continuous 21-day infusion every 28 days in platinum pre-treated ovarian carcinoma
- poster
- (1997) Eur J Cancer , vol.33
- Johnson, S.¹ Pyle, L.² King, K.³ Gore, M.⁴

20
- 0025899042
- A late phase II study of CPT-11 on uterine cervical cancer and ovarian cancer
- Resarch Groups of CPT-11 in Gynecologic Cancers
- (1991) Gan To Kagaku Ryoho , vol.18 , pp. 1681-1689
- Takeuchi, S.¹ Dobashi, K.² Fujimoto, S.³ Tanaka, K.⁴ Suzuki, M.⁵ Terashima, Y.⁶ Hasumi, K.⁷ Akiya, K.⁸ Negishi, Y.⁹ Tamaya, T.¹⁰

21
- 0035135474
- Weekly irinotecan and cisplatin in advanced non-small cell lung cancer: A multicenter phase II study
- (2001) Clin Cancer Res , vol.7 , pp. 68-73
- Jagasia, M.H.¹ Langer, C.J.² Johnson, D.H.³ Yunus, F.⁴ Rodgers, J.S.⁵ Schlabach, L.L.⁶ Cohen, A.G.⁷ Shyr, Y.⁸ Carbone, D.P.⁹ Devore, R.F.¹⁰

22
- 0010267346
- Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly
- (1994) Cancer Res , vol.54 , pp. 1220-1226
- Haas, N.B.¹ LaCreta, F.P.² Walczak, J.³ Hudes, G.R.⁴ Brennan, J.M.⁵ Ozols, R.F.⁶ O'Dwyer, P.J.⁷

23
- 0031781459
- Randomized phase II study of two schedules of topotecan in previously treated patients with ovarian cancer: A National Cancer Institute of Canada Clinical Trials Group study
- (1998) J Clin Oncol , vol.16 , pp. 2233-2337
- Hoskins, P.¹ Eisenhauer, E.² Beare, S.³ Roy, M.⁴ Drouin, P.⁵ Stuart, G.⁶ Bryson, P.⁷ Grimshaw, R.⁸ Capstick, V.⁹ Zee, B.¹⁰

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.